术前鉴定感染微生物对单期翻修髋关节置换术治疗假体周围感染是否必要
该研究回顾了2006至2015年间在本院因深部感染行单期翻修髋关节置换术的105例患者,按术前是否鉴定出感染微生物分为A组(28例,已鉴定)和B组(77例,未鉴定)。结果显示两组的再感染率(3.6% vs 9.1%,P=.679)和再翻修率(7.1% vs 9.1%,P=1.00)无显著差异,6年假体生存率为87.9%(95%CI 97.4-78.4)。作者认为术前未鉴定出微生物并非单期翻修的绝对禁忌证。
要点
- 单期翻修髋关节置换术后再感染率在术前鉴定出微生物组为3.6%,未鉴定出组为9.1%,两组无显著差异(P=.679)。
- 再翻修率在鉴定组为7.1%,未鉴定组为9.1%,两组无显著差异(P=1.00)。
- 6年总体假体生存率为87.9%(95%CI 97.4-78.4)。
核心结论
- 单期翻修的感染根除率和总体生存率与文献报道相似。
- 虽然术前鉴定感染微生物是理想的,但本研究发现术前鉴定微生物并未影响结局。
- 鉴于单期翻修的功能和经济益处,作者建议术前未能鉴定出微生物并非该方法的绝对禁忌证。
研究设计与样本
- 回顾性研究,纳入2006年至2015年间在本院因深部感染行单期翻修髋关节置换术的所有患者,共105例。
- 根据术前是否鉴定出感染微生物分为两组:A组(已鉴定)28例,B组(未鉴定)77例。
主要发现
- 再感染率:A组3.6%,B组9.1%,P=.679。
- 再翻修率:A组7.1%,B组9.1%,P=1.00。
- 6年总体假体生存率为87.9%(95%CI 97.4-78.4)。
- B组中术前关节穿刺率为36.4%(28/77)。
- 葡萄球菌属为主要致病菌,革兰阴性菌参与占19.0%(20/105)。
临床怎么用
- 作者建议:术前未能鉴定出感染微生物并非单期翻修髋关节置换术的绝对禁忌证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is commonly stated that identification of the infecting organism is a prerequisite to single-stage revision arthroplasty of the hip for deep infection. We have performed single-stage revision in a series of patients where the organism was not identified preoperatively. The aim of this study is to investigate whether the rate of infection eradication following single-stage revision was affected by preoperative knowledge of the infecting organism. METHODS: We identified all patients who had undergone a single-stage revision for a deep infection at our hospital between 2006 and 2015. One hundred five patients were assigned into 2 groups based upon whether the infecting organism had been identified preoperatively (group A = 28) or not (group B = 77). RESULTS: The reinfection rates were 3.6% in group A and 9.1% for group B (P = .679). Re-revision rates were 7.1% and 9.1%, respectively (P = 1.00). Overall, the implant survival rate at 6 years was 87.9% (95% confidence interval, 97.4-78.4). In group B, preoperative aspiration was performed in 36.4% (28/77) of cases. Staphylococci species were the predominant causative organisms, with gram-negative involvement in 19.0% (20/105) of cases. CONCLUSION: The rate of infection eradication and overall survivorship with single-stage revision was similar in our series to that reported in the literature. While desirable, we did not find identification of the infecting organism before surgery influenced the outcome. Given the functional and economic benefits of single-stage revision, we suggest that failure to identify an organism is not an absolute contraindication to this approach.
引用
- Greenfield BJ, Wynn Jones H, Siney PD, et al. Is Preoperative Identification of the Infecting Organism Essential Before Single-Stage Revision Hip Arthroplasty for Periprosthetic Infection? J Arthroplasty. 2020. PMID: 32919850. doi:10.1016/j.arth.2020.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。